Afferent fiber-selective shift in opiate potency following targeted opioid receptor knockdown

Pain

Volumn 106, Issue 3, 2003, Pages 365-371

  Jones, Toni L ^a   Sweitzer, Sarah M ^a   Wilson, Steven P ^b   Yeomans, David C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

C fibers; Herpes simplex virus; Opioid receptor; Thermal hyperalgesia

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU OPIATE RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; ENHANCER REGION; ESCHERICHIA COLI; EXPRESSION VECTOR; HUMAN CYTOMEGALOVIRUS; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INJECTION SITE; LACTOSE OPERON; MALE; MARKER GENE; MOUSE; NONHUMAN; PAIN RECEPTOR; PRIMARY AFFERENT DEPOLARIZATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; RECEPTOR OCCUPANCY; SENSORY NERVE CELL; SPINAL CORD DORSAL HORN; VIRUS RECOMBINANT; VIRUS STRAIN; WITHDRAWAL REFLEX;

EID: 0345600023     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2003.08.006     Document Type: Article

References (34)

1. Abbadie C., Lombard M.C., Besson J.M., Trafton J.A., Basbaum A.I. Mu and delta opioid receptor-like immunoreactivity in the cervical spinal cord of the rat after dorsal rhizotomy or neonatal capsaicin: an analysis of pre- and postsynaptic receptor distributions. Brain Res. 930:2002;150-162.
2. Arvidsson U., Riedl M., Chakrabarti S., Lee J.H., Nakano A.H., Dado R.J., Loh H.H., Law P.Y., Wessendorf M.W., Elde R. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci. 15:1995;3328-3341.
3. Besse D., Lombard M.C., Zajac J.M., Roques B.P., Besson J.M. Pre- and postsynaptic location of mu, delta and kappa opioid receptors in the superficial layers of the dorsal horn of the rat spinal cord. Prog Clin Biol Res. 328:1990;183-186.
4. Bolon B., Galbreath E. Use of genetically engineered mice in drug discovery and development: wielding Occam's razor to prune the product portfolio. Int J Toxicol. 21:2002;55-64.
5. Braz J., Beaufour C., Coutaux A., Epstein A.L., Cesselin F., Hamon M., Pohl M. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J Neurosci. 21:2001;7881-7888.
6. Burton E.A., Bai Q., Goins W.F., Glorioso J.C. Targeting gene expression using HSV vectors. Adv Drug Deliv Rev. 53:2001;155-170.
7. Burton E.A., Fink D.J., Glorioso J.C. Gene delivery using herpes simplex virus vectors. DNA Cell Biol. 21:2002;915-936.
8. Coggeshall R.E., Chung K., Chung J.M., Langford L.A. Primary afferent axons in the tract of Lissauer in the monkey. J Comp Neurol. 196:1981;431-442.
9. Cooper B.Y., Vierck C.J. Jr., Yeomans D.C. Selective reduction of second pain sensations by systemic morphine in humans. Pain. 24:1986;93-116.
10. Decosterd I., Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain. 87:2000;149-158.
11. Fitzgerald M. The course and termination of primary afferent fibers. Wall P. Textbook of pain. 1989;46-62 Churchill Livingstone, Edinburgh.
12. Gamse R., Holzer P., Lembeck F. Indirect evidence for presynaptic location of opiate receptors on chemosensitive primary sensory neurones. Naunyn Schmiedebergs Arch Pharmacol. 308:1979;281-285.
13. Howard M.K., Kershaw T., Gibb B., Storey N., MacLean A.R., Zeng B.Y., Tel B.C., Jenner P., Brown S.M., Woolf C.J., Anderson P.N., Coffin R.S., Latchman D.S. High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5. Gene Ther. 5:1998;1137-1147.
14. Hylden J.L., Wilcox G.L. Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res. 217:1981;212-215.
15. Ji R.R., Zhang Q., Law P.Y., Low H.H., Elde R., Hokfelt T. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci. 15:1995;8156-8166.
16. Jones TL, Wilson SP, Yeomans DC. Exposure of skin to herpes virus encoding antisense for mu-opioid receptors alters responses to DAMGO. 26th Annual Society for Neuroscience, New Orleans, LA; 2000.
17. Julius D., Basbaum A.I. Molecular mechanisms of nociception. Nature. 413:2001;203-210.
18. Lamotte C., Pert C.B., Snyder S.H. Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section. Brain Res. 112:1976;407-412.
19. Lowenstein P.R., Castro M.G. Genetic engineering within the adult brain: implications for molecular approaches to behavioral neuroscience. Physiol Behav. 73:2001;833-839.
20. Lu Y., Pirec V., Yeomans D.C. Differential antinociceptive effects of spinal opioids on foot withdrawal responses evoked by C fibre or A delta nociceptor activation. Br J Pharmacol. 121:1997;1210-1216.
21. Molander C., Xu Q., Grant G. The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J Comp Neurol. 230:1984;133-141.
22. Price D.D., Dubner R. Mechanisms of first and second pain in the peripheral and central nervous systems. J Invest Dermatol. 69:1977;167-171.
23. Proudfit H., Yeomans D. The modulation of nociception by enkephalin-containing neurons in the brainstem. Tseng L.F. Pharmacology of opioid peptides. 1995;Harwood, Amsterdam.
24. Taddese A., Nah S.Y., McCleskey E.W. Selective opioid inhibition of small nociceptive neurons. Science. 270:1995;1366-1369.
25. Tallarida R.J. Drug synergism and dose-effect data analysis. 2000;CRC Press, New York. p. 44-50.
26. Tenser R.B., Hay K.A., Edris W.A. Latency-associated transcript but not reactivatable virus is present in sensory ganglion neurons after inoculation of thymidine kinase-negative mutants of herpes simplex virus type 1. J Virol. 63:1989;2861-2865.
27. Wilson S.P., Yeomans D.C. Virally mediated delivery of enkephalin and other neuropeptide transgenes in experimental pain models. Ann N Y Acad Sci. 971:2002;515-521.
28. Wilson S.P., Yeomans D.C., Bender M.A., Lu Y., Goins W.F., Glorioso J.C. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci USA. 96:1999;3211-3216.
29. Yaksh T.L., Noueihed R. The physiology and pharmacology of spinal opiates. Annu Rev Pharmacol Toxicol. 25:1985;433-462.
30. Yang L., Voytek C.C., Margolis T.P. Immunocytochemical analysis of primary sensory neurons latently infected with herpes simplex virus 1. J Virol. 74:2000;209-217.
31. Yeomans D.C., Cooper B.Y., Vierck C.J. Jr. Effects of systemic morphine on responses of primates to first or second pain sensations. Pain. 66:1996;253-263.
32. Yeomans D.C., Pirec V., Proudfit H.K. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: behavioral evidence [see comments]. Pain. 68:1996;133-140.
33. Yeomans D.C., Proudfit H.K. Characterization of the foot withdrawal response to noxious radiant heat in the rat. Pain. 59:1994;85-94.
34. Yeomans D.C., Proudfit H.K. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiological evidence. Pain. 68:1996;141-150.